4/A
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000002
CEO bought 20,601,123 shares at an average $0.02 ($852)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Collier Alan Brian CEO | 2015-06-15 | Purchase | +19,226,657 | 19,226,657 | I | ||
| Collier Alan Brian CEO | 2015-06-15 | Purchase | +329,466 | 19,556,123 | D | ||
| Collier Alan Brian CEO | 2016-06-20 | Purchase | +1,000,000 | 20,556,123 | D | ||
| Collier Alan Brian CEO | 2019-01-09 | Purchase | +10,000 | $0.02 | $189 | 20,566,123 | D |
| Collier Alan Brian CEO | 2019-01-09 | Purchase | +10,000 | $0.02 | $188 | 20,576,123 | D |
| Collier Alan Brian CEO | 2019-01-09 | Purchase | +10,000 | $0.02 | $190 | 20,586,123 | D |
| Collier Alan Brian CEO | 2019-01-09 | Purchase | +5,000 | $0.02 | $95 | 20,591,123 | D |
| Collier Alan Brian CEO | 2019-01-09 | Purchase | +5,000 | $0.02 | $95 | 20,596,123 | D |
| Collier Alan Brian CEO | 2019-01-09 | Purchase | +5,000 | $0.02 | $95 | 20,601,123 | D |
| Open-market purchases · 20,601,123 sh · avg $0.02 · $852 | |||||||
Loading xslF345X03/primary_doc.xml…